bioAffinity Technologies, Inc.
BIAF- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001712762
No open-market purchases or sales by bioAffinity Technologies, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $782.5K in total; no superinvestor holds it.
Other share classesBIAFW
Q1 2026 vs. Q4 2025
How the institutions holding bioAffinity Technologies, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 9 | 14 | +5 |
| Shares | 78.4K | 242.2K | +163.8K (+208.8%) |
| Value | $92.5K | $928.5K | +$835.9K (+903.3%) |
New holders (8)
Institutions that held bioAffinity Technologies, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 55,543 | $212.7K | 0.00% |
| J. Safra Sarasin Holding AG | 42,600 | $164.0K | 0.00% |
| Vanguard Fiduciary Trust Co | 31,071 | $119.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 24,413 | $93.5K | 0.00% |
| State Street Corp | 14,386 | $55.1K | 0.00% |
| UBS Group AG | 9,214 | $35.3K | 0.00% |
| Ameritas Advisory Services, LLC | 1,000 | $3.83K | 0.00% |
| Caitong International Asset Management Co., Ltd | 1 | $4 | 0.00% |
Sold out (3)
Institutions that held bioAffinity Technologies, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Citadel Advisors LLC | 11,631 | $13.7K |
| Two Sigma Securities, LLC | 11,125 | $13.1K |
| Bank of America Corp | 38 | $45 |